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Background: The sitting position during neurosurgical operations predisposes to air penetration through veins and
the movement of the air through the pulmonary circulation. Contact of an air bubble with the endothelium can
lead to acute lung injury. The presence of specific pulmonary proteins in the plasma such as surfactant protein D
(SP-D) and Clara cell protein (CC16) is a biomarker of damaging processes at the air-blood barrier. The aim of our
study was to examine the hypothesis that the level of investigated pulmonary biomarkers in plasma is higher in
patients operated on in the sitting position.
Methods: The study included patients undergoing planned neurosurgical operations, who were divided into two
groups: the sitting group (40 patients, operated on in the sitting position) and the supine group (24 patients,
operated in the supine position). After the operation blood samples were drawn, centrifuged, frozen and stored
until analyses were conducted. The determination of the SP-D and CC16 levels was performed using an ELISA test.
Air embolism (VAE) was defined as a sudden drop in etCO2 of more than 2 mmHg and the presence of air bubbles
in the aspirated blood from the central cannula. In all patients, the number of hospitalization days in the
postoperative period was calculated.
Results: There were no differences in the average levels of SP-D between the groups (the mean in the sitting
group was 95.56 ng/mL and the mean in the supine group was 101.21 ng/mL). The average levels of CC16 were
similar in both groups as well (6.56ng/mL in the sitting group and 6.79ng/mL in the supine group). There was a
statistically significant positive correlation between SP-D and CC16 values in both groups. VAE was diagnosed
clinically in 12.5% of cases in the sitting group without a significant increase in SP-D and CC16 levels. On average,
patients in both groups were discharged from the hospital within 9 days of surgery.
Conclusion: The sitting position and intraoperative VAE during neurosurgical procedures do not affect the
concentration of plasma biomarkers of pulmonary parenchymal injury such as SP-D and CC16.
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In 1821, Magendie published the first report of intra-
operative pulmonary air embolism. The case occurred
during a procedure to remove a tumor from the neck
carried out in the sitting position. The patient did not
survive the operation [1]. Since then the challenges and
potential complications of the sitting position in* Correspondence: izaduda@neostrada.pl
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reproduction in any medium, provided the orneurosurgery have been widely discussed, especially with
regard to intraoperative air embolism [2-5].
Placing the patient in the sitting position during
neurosurgical procedures when the operative site lies
above the right atrium of the heart predisposes to air en-
trainment through damaged vein. The incidence of air
embolism (diagnosis) in these cases ranges from 5% to
83%, depending on the method of air detection [6,7].
When large volumes of air are rapidly entrained, the
diagnosis of air embolism can be made easily. Obstruc-
tion of pulmonary venous blood flow by air bubblestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the work of the right ventricle. This situation leads to a
decrease in cardiac preload, a reduction in cardiac out-
put and cardiovascular depression. However, the most
common form of venous air embolism has a more in-
sidious character. A series of air bubbles similar to a
string of pearls enters the venous circulation is then
carried through the right atrium, right ventricle and pul-
monary artery to the lungs. In the pulmonary circula-
tion, lipid particles, fibrin fibres and platelet aggregates
are deposited on gas bubbles, and as a consequence in-
flammatory mediators and vasoconstricting factors are
released. The mechanical contact of the gas bubble with
endothelium results in increased vascular permeability.
Histologically, thickening of the lung interstitium between
the pulmonary alveolar basement membrane and capillary
endothelium is evident. Inflammatory cells penetrate the
interstitium and alveoli damaging the endothelium and
provoking acute lung injury [8].
The lung epithelium produces a complex array of
secretions, including surfactant and several proteins im-
portant for protective immunity and lung function.
Some of these proteins are present in small quantities in
the blood as well as the bronchoalveolar fluid. As these
proteins are mainly, if not exclusively, secreted within
the airways their appearance in the vascular compart-
ment is assumed to result from leakage from the lungs
into the blood.
Thus, they can be used as biomarkers of lung injury
and the presence of these proteins in the blood reflects
the extent of alveolar dysfunction at the air-blood
barrier [9,10].
Specific endogenous lung proteins, such as surfactant
proteins A and B (SP-A and SP-B) were first detected in
the blood of children with respiratory distress syndrome
(RDS) by Chida and colleagues [11] Later, Bernard and
colleagues reported the presence of Clara cell protein in
plasma [12], and since then interest in the field has
grown considerably, reflecting the scientific and clinical
importance of identifying biomarkers of respiratory
pathophysiology [13-15]. The most important markers
detected in plasma of patients with lung injury are those
specific to the epithelium, namely SP-A and surfactant
protein D (SP-D), Krebs von den Lungen mucin (KL-6),
Clara cell protein (CC16 ), cytokeratin (CK19), carbohy-
drate antigen (CA 19–9) and carbohydrate antigen sialyl
Lewis (SLX) [16].
SP-D plays a role in immune defence by acting as an
opsonin to enhance phagocytosis and appears to be the
protein whose concentration is best correlated with the
extent of pulmonary parenchymal damage [10].
CC-16 is a low molecular weight protein secreted
mainly into the airways by non-ciliated Clara cells. Al-
though its function is not known, the concentration ofCC16 in the plasma is increased in certain diseases
caused by damage to the air-blood barrier [10].
We hypothesized that the air microbubbles that enter
the venous system during neurosurgery in the sitting
position increase the levels of SP-D and CC16 in the
blood that the extend of venous air embolism correlates
with the concentration of these biomarkers.Methods
The study was approved by the Bioethics Committee.
Written informed consent was obtained from all
patients. Patients scheduled for elective intracranial
operations with an estimated duration of 4 h or more
were consecutively enrolled in this prospective observa-
tional study. Patients were divided into two groups those
who underwent craniectomy for pathology in the poster-
ior fossa and a control group who underwent surgery in
the supine position for supratentorial lesions. Patients
with a history of pulmonary disease (chronic obstructive
pulmonary disease, pneumonia, pulmonary embolism,
pulmonary fibrosis, previous lung resection or lung
tumour), immunosuppressed patients, pregnant women
and patients with serious comorbidities (American Soci-
ety of Anesthesiologists status IV and V) were excluded
from this study.
All patients were anesthetised and ventilated according
to the following protocol. Anaesthesia was induced with
of propofol (6–12 mg kg-1) and remifentanil (0.5-0.9
mcg kg-1). Cisatracurium was used to facilitate intub-
ation and to maintain neuromuscular blockade. Anaes-
thesia was maintained with propofol (3-5mg kg-1) and
remifentanil (0.07-0.13 mcg kg-1 min-1) infusions. After
endotracheal intubation, patients were machanically ven-
tilated using intermittent positive pressure (IPPV) with
low tidal volumes (8 ml kg-1 ideal body weight). The
fraction of inspired oxygen (FiO2) was set at 40% and
the inhalation/exhalation ratio at 1:2. The ventilator
frequency was adjusted to maintain moderate hyperven-
tilation (etCO2 35–40 mmHg). A central cannula was
placed in the subclavian vein of all patients, and position
in the right atrium area was confirmed using the
electrocardiogram.
In the event of a sudden drop in etCO2 of more than
2 mmHg, blood was aspirated from the subclavian cath-
eter [3]. The presence of air bubbles led to the diagnosis
of venous air embolism.
Information regarding the number of days of
hospitalization after the surgery was collected for all of
the patients.
To determine the values of SP-D and CC16 blood
samples were collected immediately after surgery from
the venous catheter and immediately centrifuged at
1500 rpm for 10 minutes. The supernatant was frozen
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formed a sandwich-type enzyme-linked immunosorbent
assay (ELISA) technique using surfactant Protein D
Human ELISA (RD194059101, Biovendor, Czech Repub-
lic) and Clara Cell Protein Human ELISA (RD191022200,
Biovendor, Czech Republic) kits. All assays were per-
formed in duplicate by an investigator blinded to the
patients’ clinical data.Statistical analysis
Quantitative variables are presented as number, mean,
standard deviation (SD), median, minimum and max-
imum values.
The normality of the distribution of CC-16 and SP-D
levels was estimated using the Shapiro-Wilk test. The
chi-squared and Fisher’s exact tests were used to com-
pare quantitative variables. For normally distributed
data, the Student’s t-test was used to examine differences
between groups; the Mann–Whitney U test was used for
data that were not normally distributed. Spearman’s cor-
relation coefficient was employed to estimate the inci-
dence and strength of the relationship between two
quantitative variables. The research hypotheses were
verified by Levene’s test. In all analyses a significance
level of p < 0.05 was adopted. All analyses were per-




age (years) 50.5 ± 13.8
gender (M / F) 24/16
body weight (kg) 75.5 ± 13.6
ASA 1.95 ± 0.69
operation time (min) 279.37 ± 69.5
SBP (mmHg) 132.50 ± 19.2
DBP (mmHg) 75.07 ± 13.3
HR (beap / min) 80.50 ± 13.1
Saturation (%) 96.93 ± 2.3
Type of operation









Between August 2010 and June 2011, 64 patients were
enrolled in the study and divided into two groups. Forty
patients in the study group had surgery in the sitting
position (“SITTING group”) and twenty-four patients in
the control group underwent surgery in the supine pos-
ition (“SUPINE group”). The basic characteristics of all
patients are shown in Table 1.
The mean serum concentration of SP-D in the SIT-
TING group ranged from 28 to 271 ng/mL with mean
of 95.56 ng/mL ±54.01 (mean ± SD) and it was similar
to those observed in the SUPINE group (range 20–277
ng/mL; mean 101.21 ng/mL ± 73.16). There were also
no statistically significant difference in CC16 levels be-
tween the groups (p = 0.857, median concentration in
SITTING group: 5.75 ng/mL; median concentration in
SUPINE group: 5.64 ng/mL). The range of values in the
SITTING group was 3–14 ng/mL (mean 6.56 ng/mL ±
2.69 and 2–18 ng/mL ( mean 6.79 ng/mL ± 3.65) in the
SUPINE group (Figure 1).
A statistically significant, positive relationship between
the values of SP-D and CC16 in both the SITTING
group (p = 0.029) and SUPINE group (p = 0.009) was
found. If the levels of one marker increased, the levels of
the other also increased. The value of the correlation co-
efficient for the above relationship was 0.345 in the SIT-
TING group and 0.522 in the SUPINE group (Figure 2).SUPINE p-value
n=24
(mean ± SD)
47.0 ± 14.2 0.402
13/11 0.794
77.71 ± 11.9 0.432
2.25 ± 0.79 0.085
221.67 ± 75.5 0.003*
124.08 ± 17.1 0.084
77.17 ± 12.8 0.528
73.54 ± 12.8 0.036*









Figure 1 Surfactant protein D (SP-D) and Clara cell protein (CC16) concentration in patients undergoing surgery in the sitting and the
supine positions. The horizontal line represents the median; the box encompasses 25th - 75th percentiles (the interquartile range, IQR), and the
whiskers show upper and lower quartiles.
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etCO2 and confirmed by aspiration of air from the cen-
tral cannula on 5 occasions in the SITTING group
(12.5%) but was not diagnosed on any occasion in the
SUPINE group. During VAE, etCO2 fell on average by
10.6 mmHg ( range 6–20 mmHg). We did not see any
evidence of cardiovascular depression in the form of
changes in blood pressure, cardiac arrhythmias or
decreases in peripheral blood oxygen saturation in any
patient diagnosed with VAE. The duration of surgery
was, on average, 54 minutes longer when VAE was diag-
nosed (p <0.001).
In the subgroup of patients with VAE, there were
no statistically significant differences in the concentra-
tions of SP-D (p = 0.513) or CC16 (p = 0.561) comparedFigure 2 Correlation between surfactant protein D (SP-D) and Clara c
position groups.with patients without VAE. The median plasma con-
centrations of SP-D and CC16 were 69.19 ng/mL and
5.70 ng/mL respectively (Figure 3).
Patients from both groups were discharged from the
hospital on average approximately 10 days after the
surgery (p = 0.462; median 9 days for SITTING and
SUPINE).
Discussion
The main objective of this study was to determine
whether there is a difference between plasma levels of
SP-D and CC16 in patients undergoing neurosurgery in
the sitting position compared with patients operated on
in the supine position. We found that the mean concen-
trations of SP-D and CC16 were similar in both groups.ell protein (CC16) concentration in the sitting and the supine
Figure 3 Surfactant protein D (SP-D) and Clara cell protein (CC16) concentration in patients operated in the sitting position with vs.
without intraoperative air embolism (VAE). The horizontal line represents the median; the box encompasses the 25th - 75th percentiles (the
interquartile range, IRQ), and the whiskers show upper and lower quartiles.
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ition is a situation that can result in iatrogenic penetra-
tion of air into the venous system and pulmonary
circulation. Even in situations when a large air embolism
was not diagnosed intraoperatively, a gradual permeation
of air microbubbles can obstruct blood flow in distal ca-
pillaries. Reduced blood flow causes tissue ischaemia,
and the microbubbles initiate an immediate inflamma-
tory response and complement activation. VAE incidents
have been detected by transesophageal echocardiography
(TEE) in 76% of patients undergoing surgery in the sit-
ting position [17]. It is therefore reasonable to assume
that air microbubbles are present to a certain extent in
the vast majority of cases. The lung injury and endothe-
lial dysfunction that air bubbles cause have been con-
firmed in animal studies [18], although in one study that
used electron microscopy no physical damage to the
endothelium could be visualised [19], Endothelial cells
normally have tight connections to prevent leakage of
fluids into the surrounding tissues. Air bubbles in the
microcirculation cause pressure on endothelial cells and
increase the pore radius.
The appearance of gaps between endothelial cells in
leakage of fluid and consequently interstitial pulmonary
oedema [20]. In our study we did not confirm potential
lung injury based on the increased levels of pulmonary
proteins in the systemic circulation. Furthermore, we did
not observe any differences in the duration of postopera-
tive hospitalisation or the incidence of clinical symptoms
or signs between the groups.
A small amount of SP-D can be detected in the blood
of healthy individuals; the exact quantity is genetically
determined and varies between individuals. Plasma levels
of these proteins can be elevated in patients with a widevariety of diseases and after exposure to toxins. Deter-
mann and colleagues observed SP-D levels of 140 ng/mL
in patients without lung injury, which almost doubled
toh acute lung injury / acute respiratory distress syn-
drome (ALI/ARDS) [21]. However, a different study
found the mean value of SP-D to be 88 ng/mL ( range
1–1354 ng/mL) in patients with lung injury. [15] In
healthy adults and children the average level of SP-D is
approximately 60 ng/mL. [10] Increased levels of SP-D
have been reported in idiopathic pulmonary fibrosis
(IFP), tuberculosis, pulmonary alveolar proteinosis,
andlues vave ranger between 100 ng/mL (sarcoidosis) to
339 ng/mL (IPF) compared to a control group of healthy
patients (66ng/mL). However, SP-D levels do not appear
to be elevated in asthma, bacterial pneumonia, emphy-
sema, bronchitis or bronchiectasis [10,22]. In our study,
the SP-D level in healthy, mechanically ventilated
patients during craniotomy without prior lung injury
was 100 ng/mL. Mechanical ventilation can lead to
lung damage, in an animal model the consequences of
ventilator-associated lung injury (VALI) are increased
pulmonary capillary permeability and pulmonary oedema,
cellular damage and necrosis and diffuse alveolar damage.
The factors affecting the development of VALI are posi-
tive end expiratory pressure (PEEP), the respiratory rate,
pulmonary artery pressure, the arterial partial pressure of
CO2, beta-adrenergic agonists and body position [23].
Determann and colleagues. studied the effect of ventila-
tion on the levels ofSP-A, SP-D and CC16 and found that
levels did not differ in patients mechanically ventilated
with low tidal volumes and PEEP compared with a con-
ventional ventilation technique in participants undergoing
surgery in the supine position [24]. In contrast, lung
damage is significantly lower in patients ventilated in the
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larly, the sitting position appears to improve ventilation
parameters [26]. However, these observations were made
in patients who were not a risk of VAE.
The plasma CC16 concentration depends on factors
such as lipid levels, body mass index, gender and smok-
ing status, and changes can be observed in various lung
diseases and after exposure to toxins. A decrease in the
CC16 concentration was reported, for example, in smo-
kers, while in patients with interstitial lung diseases an
increase has been observed [27,28]. The plasma concen-
tration of CC16 in healthy subjects was determined to
be between 11.8 and 27.9 ng/mL [29,30]. CC16 is a small
molecule (16 kDa) and its presence in the blood is a sen-
sitive marker of alveolar damage [22]. However, in our
study CC16 concentrations were similar in both groups.
Air embolism was diagnosed in 12.5% of cases. The
incidence of intraoperative diagnosis of VAE is dep-
endent on the method of detection. The more sensitive
the method is the higher the incidence of VAE [31]. We
diagnosed VAE on the basis of a sudden fall of >2 mmHg
in end tidal CO2 (etCO2) and confirmation of the pres-
ence of air in blood drawn from the central venous
catheter. This method is capable of detecting large
embolisms, which can lead to lung injury. In our study,
potential lung damage was not confirmed on the basis
the changes detected in our chosen biomarkers. VAE
is a dynamic condition in which embolic air diffuses
across the alveolar capillaries and can thus be expelled
in approximately 30 minutes [32]. Short-term resistance
to flow in the pulmonary capillaries does not necessarily
activate the inflammatory cascades that lead to a com-
plex mechanism that results in the contact of air bubbles
with the endothelium, leading to interstitial pulmonary
oedema and then ALI/ARDS.
There were also no apparent clinical consequences of
lung damage in patients operated in the sitting position,
as the duration of hospital stay after surgery was not
prolonged.
One limitation of our study is that we only took a
blood sample once after surgery. Sampling within four
hours of placing the patients in the sitting position could
have missed later significant lung damage and thus a
later peak of blood biomarkers. More frequent sampling
could have revealed the time course of changes in bio-
markers rather than providing a snapshot. Another limi-
tation may be our choice of biomarkers and the fact
that differences may have been observed if other pro-
teins or cell-specific markers of acute lung injury and
acute inflammation had been measured.
Conclusion
In conclusion, we did not find any evidence of lung
damage in patients undergoing neurosurgery in thesitting position. Our choice of biomarkers (SP-D and
CC16) did not allow us to definitively identify whether
microbubbles of air passing into the circulatory system
lead to pulmonary endothelial damage. Therefore, our
understanding of the pathophysiological processes of
lung injury provoked by VAE is not complete and
requires further study.
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